Previous Article | Next Article ![]()
J. Virol., May 1996, 3189-3197, Vol 70, No. 5
SV Joag, Z Li, L Foresman, EB Stephens, LJ Zhao, I Adany, DM Pinson, HM McClure and O Narayan
By animal-to-animal passage of simian/human immunodeficiency virus (SHIV)
in pig-tailed macaques, we have developed a macaque model of human
immunodeficiency virus type 1 (HIV-1) disease in humans. Passaging was
begun with a chimeric virus containing the env gene of HIV-1 HXBc2 and the
gag and pol genes of simian immunodeficiency virus SIVmac239. SHIV was
passaged serially in cohorts of two macaques each, using bone
marrow-to-bone marrow transfers at 5, 5, and 16 weeks for passages 2, 3,
and 4, respectively. The fifth passage was done by using cell-free virus
isolated from cerebrospinal fluid of a passage 4 macaque. The virus became
more virulent with each passage. Virus replication was restricted in all
three animals in passages 1 and 2 but not in five of the six animals in
passages 3, 4, and 5. In these animals, intense virus replication in the
lymphoid tissues resulted in almost total elimination of CD4+ T cells
within weeks of inoculation, and three of these animals developed AIDS in
less than 1 year. The more uniform virus-host interaction initiated by the
cell-free virus in the passage 5 animals contrasted with a more variable
pattern of disease initiated by infectious bone marrow cells during earlier
passages. The virulent cell-free SHIV can now be used to screen the
efficacy of vaccines directed against the envelope of HIV-1.
Copyright © 1996, American Society for Microbiology
Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques
Marion Merrell Dow Laboratory of Viral Pathogenesis and Department of Microbiology, University of Kansas Medical Center, Kansas City 66160- 7420, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|